Clinical Trial Details

EORTC-30894

Back to Clinical Trials Database

Phase III study of primary chemotherapy (CMV) in T2G3, T3 and T4a, NO-X, M0 transitional cell carcinoma of the bladder (MRC/EORTC Collaborative Study)

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 30-Nov-1989
Date Step1 close: 30-Jun-1995
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 400
Treatment
Study Staff
Type of cancer
Participating groups EORTC Genito-Urinary Cancers Group
Protocol summary http://clinicaltrials.gov/ct/show/
NCT number